CSI Market
Sign In | Register

Q Biomed inc (QBIO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access QBIO quarterly Cash Flow →
Looking at cash flow data from Q Biomed inc through Nov 30 2017 provides insight into Nov 30 2022's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Nov 30 2022)
12 Months 		(Nov 30 2021) (Nov 30 2019) (Nov 30 2018) (Nov 30 2017)
Operating Activities
Income-2.05
Depreciation & amortization0.00
Amortization of Other Assets0.05
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.39
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.38
Issuance Of Common Stock For Research And Development-
Issuance Of Common Stock For Services To Related Parties-
Net Investment Income-
Partners Capital Account Private Placement Of Units-
Longterm Liabilities-
Change In Fair Value Of Embedded Conversion Options-
Loss On Induced Conversion Of Debt-
Gain Loss On Settlement Of Outstanding Liabilities-
Share Based Compensation Related To Warrants Modification0.30
Share Based Compensation Related To Stock Options Modification0.21
Accretion Of Debt Discount0.92
Long Term Liabilities0.18
Gain Loss On Issuance Of Convertible Note0.01
Income taxes0.00
Unrealized Gain (Loss) on Derivatives-0.27
Increase (Decrease) in Accounts Receivable0.07
Increase (Decrease) in Accounts Payable1.47
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.24
Discontinued operations0.00
Net Cash flow from Operating Activities1.94
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-3.14
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.14
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.65
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Capital Expenditure Discontinued Operations-
Proceeds Received From Issuance Of Note Payable-
Proceeds Received From Exercise Of Warrants-
Proceeds From Investor Advances-
Proceeds From Issuance Of Common Stock And Warrants0.10
Cash Advances0.14
Proceeds From Warrant Modification0.02
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.91
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.94
Total Cash Flow-0.29
4 historic quarters locked

Sign in to unlock the full Q Biomed inc cash flow history.

Sign In Create Free Account

About Q Biomed Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001410578-23-001458

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License